Abstract 2849: Pharmacodynamic biomarkers of anti-PD-L1 activity in pre-clinical mouse tumor models
Boe, Marigold, Huseni, Mahrukh, Jiang, Brittany, Koeppen, Hartmut, Maecker, Heather, Irving, Bryan, Hegde, Priti, Kowanetz, Marcin
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Abstract 4978: Lung cancers regulate the immune suppressor PD-L1 by multiple mechanisms, altering its role in tumor survival
Kadel, Edward (Ward) E., Walter, Kimberly, Desai, Rupal, Carbon, Juliet, Boe, Marigold, Shames, David, Kowanetz, Marcin
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Published in Cancer research (Chicago, Ill.) (15.04.2013)
Get full text
Journal Article
Correlation of T-cell inflamed phenotype with mesenchymal subtype, expression of PD-L1, and other immune checkpoints in head and neck cancer
Saloura, Vassiliki, Zuo, Zhixiang, Koeppen, Hartmut, Keck, Michaela K., Khattri, Arun, Boe, Marigold, Hegde, Priti S., Xiao, Yuanyuan, Nakamura, Yusuke, Vokes, Everett E., De Souza, Jonas A., Villaflor, Victoria Meucci, Kline, Justin Paul, Gajewski, Thomas, Lingen, Mark W., Kowanetz, Marcin, Seiwert, Tanguy Y.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A
Kowanetz, Marcin, Rabe, Christina, Xiao, Yuanyuan, Wu, Qun J, Koeppen, Hartmut, Leddy, Cecilia, Patel, Rajesh D, Powderly, John, Kohrt, Holbrook, Gettinger, Scott, Soria, Jean-Charles, Herbst, Roy S, Desai, Rupal, Denker, Mitchell, Ruppel, Jane, Boe, Marigold, Nakamura, Rin, Fu, Ling, Sumiyoshi, Teiko, Mokatrin, Ahmad, Shen, Xiaodong, Fine, Gregg, Chen, Daniel S, Hegde, Priti S
Published in Journal for immunotherapy of cancer (06.11.2014)
Published in Journal for immunotherapy of cancer (06.11.2014)
Get full text
Journal Article